An in silico simulation of the frequency of administering <scp>HLA</scp>‐incompatible low titer group O whole blood units when the donor pool includes unscreened female donors
Blood collectors and hospitals should evaluate the potential TRALI risk against the benefit of a potentially expanded inventory of LTOWB before collecting plasma-containing products from non-HLA-tested parous female donors.
Authors
- Jansen N. Seheult (ORCID: https://orcid.org/0000-0002-6850-7495)
- Audra L. Taylor
- Samantha Ngamsuntikul
- Mark H. Yazer (ORCID: https://orcid.org/0000-0001-6740-2758)
- Manish J. Gandhi (ORCID: https://orcid.org/0000-0001-7210-1909)
- Torunn Oveland Apelseth (ORCID: https://orcid.org/0000-0001-8823-2719)
Institutions
- Mayo Clinic (US)
- University of Pittsburgh (US)
- Haukeland University Hospital (NO)
- South Texas Blood and Tissue Center (US)
- University of Bergen (NO)
Publication Details
- Journal
- Transfusion
- Published
- 2025-02-05
- DOI
- https://doi.org/10.1111/trf.18141
- Citations
- 1
- Primary Topic
- Blood groups and transfusion
- Type
- article
- Field-Weighted Citation Impact
- 1.77